ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
US FDA approves Siliq to treat plaque psoriasis
pharmaceutical-technology
February 17, 2017FDA Center for Drug Evaluation and Research Office of Drug Evaluation III director Julie Beitz said: "Moderate-to-severe plaque psoriasis can cause significant skin irritation and discomfort for patients, and today’s approval provides patients with anothe -
Siliq Approved By the FDA for Adult Patients with Moderate-to-Severe Plaque Psoriasis
americanpharmaceuticalreview
February 17, 2017AstraZeneca’s partner Valeant Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Siliq (brodalumab) injection for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for syst
Pharma Sources Insight January 2025
